The global fructosamine test indutry was valued at around USD 266.3 million in 2023 and is poised to exhibit a CAGR of 3.8% during the forecast period. Accordingly, total market valuation is expected to increase from USD 275.9 million in 2024 to USD 399.9 million by 2034. Several factors are anticipated to drive the growth …